BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16275757)

  • 1. The matrix protein CCN1 (CYR61) induces apoptosis in fibroblasts.
    Todorovic V; Chen CC; Hay N; Lau LF
    J Cell Biol; 2005 Nov; 171(3):559-68. PubMed ID: 16275757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted mutagenesis of the angiogenic protein CCN1 (CYR61). Selective inactivation of integrin alpha6beta1-heparan sulfate proteoglycan coreceptor-mediated cellular functions.
    Leu SJ; Chen N; Chen CC; Todorovic V; Bai T; Juric V; Liu Y; Yan G; Lam SC; Lau LF
    J Biol Chem; 2004 Oct; 279(42):44177-87. PubMed ID: 15322081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adhesion of human skin fibroblasts to Cyr61 is mediated through integrin alpha 6beta 1 and cell surface heparan sulfate proteoglycans.
    Chen N; Chen CC; Lau LF
    J Biol Chem; 2000 Aug; 275(32):24953-61. PubMed ID: 10821835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The angiogenic factor cysteine-rich 61 (CYR61, CCN1) supports vascular smooth muscle cell adhesion and stimulates chemotaxis through integrin alpha(6)beta(1) and cell surface heparan sulfate proteoglycans.
    Grzeszkiewicz TM; Lindner V; Chen N; Lam SC; Lau LF
    Endocrinology; 2002 Apr; 143(4):1441-50. PubMed ID: 11897702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts.
    Chen CC; Chen N; Lau LF
    J Biol Chem; 2001 Mar; 276(13):10443-52. PubMed ID: 11120741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells.
    Leu SJ; Lam SC; Lau LF
    J Biol Chem; 2002 Nov; 277(48):46248-55. PubMed ID: 12364323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel integrin alpha 6 beta 1 binding site in the angiogenic inducer CCN1 (CYR61).
    Leu SJ; Liu Y; Chen N; Chen CC; Lam SC; Lau LF
    J Biol Chem; 2003 Sep; 278(36):33801-8. PubMed ID: 12826661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional properties and intracellular signaling of CCN1/Cyr61.
    Chen Y; Du XY
    J Cell Biochem; 2007 Apr; 100(6):1337-45. PubMed ID: 17171641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of integrin alpha(M)beta(2) as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): immediate-early gene products expressed in atherosclerotic lesions.
    Schober JM; Chen N; Grzeszkiewicz TM; Jovanovic I; Emeson EE; Ugarova TP; Ye RD; Lau LF; Lam SC
    Blood; 2002 Jun; 99(12):4457-65. PubMed ID: 12036876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYR61 stimulates human skin fibroblast migration through Integrin alpha vbeta 5 and enhances mitogenesis through integrin alpha vbeta 3, independent of its carboxyl-terminal domain.
    Grzeszkiewicz TM; Kirschling DJ; Chen N; Lau LF
    J Biol Chem; 2001 Jun; 276(24):21943-50. PubMed ID: 11287419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fas-mediated apoptosis is regulated by the extracellular matrix protein CCN1 (CYR61) in vitro and in vivo.
    Juric V; Chen CC; Lau LF
    Mol Cell Biol; 2009 Jun; 29(12):3266-79. PubMed ID: 19364818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNFα-induced apoptosis enabled by CCN1/CYR61: pathways of reactive oxygen species generation and cytochrome c release.
    Juric V; Chen CC; Lau LF
    PLoS One; 2012; 7(2):e31303. PubMed ID: 22363611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel CYR61-triggered 'CYR61-alphavbeta3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway.
    Menendez JA; Vellon L; Mehmi I; Teng PK; Griggs DW; Lupu R
    Oncogene; 2005 Jan; 24(5):761-79. PubMed ID: 15592521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix protein CCN1 is critical for prostate carcinoma cell proliferation and TRAIL-induced apoptosis.
    Franzen CA; Chen CC; Todorović V; Juric V; Monzon RI; Lau LF
    Mol Cancer Res; 2009 Jul; 7(7):1045-55. PubMed ID: 19584265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of the angiogenic/senescence inducer CCN1/CYR61 to integrin α
    Espinoza I; Yang L; Steen TV; Vellon L; Cuyàs E; Verdura S; Lau L; Menendez JA; Lupu R
    Aging (Albany NY); 2022 Feb; 14(3):1200-1213. PubMed ID: 35148282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxicity of TNFalpha is regulated by integrin-mediated matrix signaling.
    Chen CC; Young JL; Monzon RI; Chen N; Todorović V; Lau LF
    EMBO J; 2007 Mar; 26(5):1257-67. PubMed ID: 17318182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-derived Cyr61(CCN1) promotes stromal matrix metalloproteinase-1 production and protease-activated receptor 1-dependent migration of breast cancer cells.
    Nguyen N; Kuliopulos A; Graham RA; Covic L
    Cancer Res; 2006 Mar; 66(5):2658-65. PubMed ID: 16510585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction and function of CYR61 (CCN1) in prostatic stromal and epithelial cells: CYR61 is required for prostatic cell proliferation.
    Sakamoto S; Yokoyama M; Aoki M; Suzuki K; Kakehi Y; Saito Y
    Prostate; 2004 Dec; 61(4):305-17. PubMed ID: 15389821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cysteine-rich 61 (CCN1) enhances chemotactic migration, transendothelial cell migration, and intravasation by concomitantly up-regulating chemokine receptor 1 and 2.
    Lin BR; Chang CC; Chen LR; Wu MH; Wang MY; Kuo IH; Chu CY; Chang KJ; Lee PH; Chen WJ; Kuo ML; Lin MT
    Mol Cancer Res; 2007 Nov; 5(11):1111-23. PubMed ID: 18025257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCN1 protects cardiac myocytes from oxidative stress via beta1 integrin-Akt pathway.
    Yoshida Y; Togi K; Matsumae H; Nakashima Y; Kojima Y; Yamamoto H; Ono K; Nakamura T; Kita T; Tanaka M
    Biochem Biophys Res Commun; 2007 Apr; 355(3):611-8. PubMed ID: 17316559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.